Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis

Clinical trial NCT00395772 · COMPLETED

Trial details

NCT number: NCT00395772
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2004-12-01
Enrollment: 543

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.